Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for Fibrosis in Hypertrophic Cardiomyopathy
NCT00879060Phase 4Completed
- Sponsor
- Tufts Medical Center
- Start
- Nov 2007
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in hypertrophic cardiomyopathy (HCM), sponsored by Tufts Medical Center. Started Nov 2007; status: completed.
02
Drugs
spironolactone
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT00879060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00879060.